The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
Article in Nature Communications (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Nature Communications (August 2024)
Article in Annals of Hematology (June 2024)
Article in American Society of Clinical Oncology Educational Book (June 2024)